These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 21719871)

  • 21. Disclosure.
    J Am Coll Radiol; 2019 Mar; 16(3):269-270. PubMed ID: 30832824
    [No Abstract]   [Full Text] [Related]  

  • 22. Competing interests.
    Sharpe VA; Gurian-Sherman D
    Nat Biotechnol; 2003 Oct; 21(10):1131. PubMed ID: 14520389
    [No Abstract]   [Full Text] [Related]  

  • 23. [Publication ethics: regulation of financial conflicts of interests in medical journals].
    Kakuk P
    Lege Artis Med; 2011 Jan; 21(1):65-71. PubMed ID: 21469379
    [No Abstract]   [Full Text] [Related]  

  • 24. Response to "the corporate coauthor".
    Wager E; Jacobs A
    J Gen Intern Med; 2005 Jul; 20(7):672. PubMed ID: 16050869
    [No Abstract]   [Full Text] [Related]  

  • 25. Public trust requires disclosure of potential conflicts of interest.
    Gurney S; Sass J
    Nature; 2001 Oct; 413(6856):565. PubMed ID: 11595911
    [No Abstract]   [Full Text] [Related]  

  • 26. Medicine in small doses.
    Waxman BP
    ANZ J Surg; 2017 Jul; 87(7-8):538. PubMed ID: 28768382
    [No Abstract]   [Full Text] [Related]  

  • 27. Promoting ethical integrity in publishing.
    Peternelj-Taylor C
    J Forensic Nurs; 2013; 9(2):65-7. PubMed ID: 24158136
    [No Abstract]   [Full Text] [Related]  

  • 28. Re: Regulatory Toxicology and Pharmacology.
    Merkel-Sobotta E
    Int J Occup Environ Health; 2003; 9(4):390; author reply 390-1. PubMed ID: 14664494
    [No Abstract]   [Full Text] [Related]  

  • 29. Re: Regulatory Toxicology and Pharmacology.
    Axelson O; Balbus JM; Cohen G; Davis D; Donnay A; Doolittle R; Duran BM; Egilman D; Epstein SS; Goldman L; Grandjean P; Hansen ES; Heltne P; Huff J; Infante P; Jacobson MF; Joshi TK; LaDou J; Landrigan PJ; Lee PR; Lockwood AH; MacGregor G; Melnick R; Messing K; Needleman H; Ozonoff D; Ravanesi B; Richter ED; Sass J; Schubert D; Suzuki D; Teitelbaum D; Temple NJ; Terracini B; Thompson A; Tickner J; Tomatis L; Upton AC; Whyatt RM; Wigmore D; Wilson T; Wing SB; Sharpe VA
    Int J Occup Environ Health; 2003; 9(4):386-9; author reply 389-90. PubMed ID: 14664493
    [No Abstract]   [Full Text] [Related]  

  • 30. Industry involvement in preparation of articles.
    Cleve Clin J Med; 2005 Jun; 72(6):462-3; author reply 463. PubMed ID: 16018288
    [No Abstract]   [Full Text] [Related]  

  • 31. A matter of trust.
    Nat Immunol; 2006 Oct; 7(10):1005. PubMed ID: 16985491
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pitfalls in the publication of scientific literature: a road map to manage conflict of interest and other ethical challenges.
    Patel AA; Whang PG; White AP; Fehlings MG; Vaccaro AR
    J Neurosurg; 2011 Jan; 114(1):21-6. PubMed ID: 20849217
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ethical integrity is the sine qua non of scientific reporting.
    Dinges DF
    Sleep; 2010 Feb; 33(2):141-2. PubMed ID: 20175394
    [No Abstract]   [Full Text] [Related]  

  • 34. Conflicts of interest, authorship, and disclosures in industry-related scientific publications.
    Garber JR
    Mayo Clin Proc; 2010 Feb; 85(2):196; author reply 201-4. PubMed ID: 20118397
    [No Abstract]   [Full Text] [Related]  

  • 35. Conflicts of interest, authorship, and disclosures in industry-related scientific publications.
    Jung BC
    Mayo Clin Proc; 2010 Feb; 85(2):199; author reply 201-4. PubMed ID: 20118401
    [No Abstract]   [Full Text] [Related]  

  • 36. Ghostwriters in the fray: the implications for science, industry, medical journals, and our patients.
    Salcido R
    Adv Skin Wound Care; 2009 Nov; 22(11):494-6. PubMed ID: 20026926
    [No Abstract]   [Full Text] [Related]  

  • 37. The sins of ghostwriting.
    Somberg JC
    Am J Ther; 2008; 15(4):297-8. PubMed ID: 18645328
    [No Abstract]   [Full Text] [Related]  

  • 38. The corporate coauthor.
    Fugh-Berman A
    J Gen Intern Med; 2005 Jun; 20(6):546-8. PubMed ID: 15987332
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Conflicts of interest/transparency declarations: new policy.
    Jeeves CL; Drummond CW; Reeves DS
    J Antimicrob Chemother; 2005 Oct; 56(4):609-10. PubMed ID: 16144870
    [No Abstract]   [Full Text] [Related]  

  • 40. Editorial: conflicts of interest in publication about families and family therapy.
    Lebow JL
    Fam Process; 2015 Jun; 54(2):199-204. PubMed ID: 26058868
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.